Reducing antipsychotic medication: a case study
Part of Mental health clinical trials.
This study looks at safely reducing or stopping antipsychotic medication in adults with psychotic disorders who are stable and interested in trying. It aims to understand how to best support patients during this process.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a psychotic or related disorder.
- You have been taking antipsychotic medication for a long time.
- Your symptoms are currently stable.
- You want to try reducing or stopping your antipsychotic medication between January 2021 and October 2025.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing whether it is safe to slowly reduce or stop anticholinergic medications (benztropine or trihexyphenidyl) in people with schizophrenia. It aims to see if stopping these drugs can help with thinking and memory without causing worsening movement problems.
This study tests whether gradually reducing the dose of antipsychotic medication is as safe and effective as staying on the current dose for people with stable schizophrenia spectrum disorder. It aims to personalize treatment to find the lowest effective dose for each person.
This study looks at whether people can safely lower or stop their antidepressant medication with support from their primary care doctor. It's for adults who have been taking an antidepressant for at least a year and can visit their health center.
This trial tests different ways to safely stop taking antidepressants for people whose depression is in remission. It aims to find the best strategy to reduce withdrawal and prevent relapse.
This study tests whether adding N-Acetylcysteine (a supplement) can help safely reduce antipsychotic medication in people with stable psychosis. If you are doing well on a steady dose of antipsychotics, you may be able to gradually lower your dose while taking this supplement.
This study tests whether patients with schizophrenia can safely stop or reduce their current medication without worsening symptoms. It is designed for people who need ongoing psychiatric care.
Hear when a new Psychotic Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.